
We're pioneering cellular agriculture to create the cleanest, most sustainable seafood11-50 Employees
- B2C
- Scale StageRapidly increasing operations
- Top InvestorsThis company has received a significant amount of investment from top investors
Wildtype careers
Wildtype is on a mission to create the cleanest, most sustainable seafood on the planet, starting with sushi-grade salmon. We’re pioneering cellular agriculture to protect wild species and our oceans, and to reverse trends of global food insecurity. Wildtype will provide consumers with a new option for real seafood that provides the same nutritional benefits as the most pristine wild-caught fish, without common contaminants such as mercury, microplastics, antibiotics, or pesticides.
We were founded in 2016 by Aryé Elfenbein (Chief Scientist), a cardiologist and molecular biologist, and Justin Kolbeck (CEO), a former US diplomat who served in Pakistan and Afghanistan, in an effort to solve one of the world’s biggest problems: how to feed a growing population without stripping the earth of its natural resources and biodiversity. Investors include Spark Capital, Charles River Ventures, Root Ventures, Alexis Ohanian and Kyle Vogt, among others.
Come join us in transforming our food system for good!
We were founded in 2016 by Aryé Elfenbein (Chief Scientist), a cardiologist and molecular biologist, and Justin Kolbeck (CEO), a former US diplomat who served in Pakistan and Afghanistan, in an effort to solve one of the world’s biggest problems: how to feed a growing population without stripping the earth of its natural resources and biodiversity. Investors include Spark Capital, Charles River Ventures, Root Ventures, Alexis Ohanian and Kyle Vogt, among others.
Come join us in transforming our food system for good!
Wildtype hasn't added any jobs yet
Get notified when Wildtype posts new jobs.
Justin Kolbeck
Co-founder and CEO of Wildtype; former strategy consultant and diplomat with service in Afghanistan, Pakistan, and Australia. Father of two, and lover of the outdoors.
Valuation
$0
Funded over
2 rounds
Latest round
Series A (Oct 2019)
Movable Ink • New York City • $123k – $160k • 1 week ago
Amgen • Thousand Oaks • $171k – $232k • 1 week ago
Pacific Biosciences • Menlo Park • $148k – $222k • 1 week ago
Glaxosmithkline • Seattle • $158k – $264k • 2 weeks ago
AllTrails • San Francisco • $85k – $110k • 2 weeks ago